develops in an intubated patient on mechanical ventilation support 7 and is identified using a combination of radiological, clinical, and laboratory criteria. 8 There is no minimum period that the ventilator must be in place in order for the pneumonia to be considered ventilator associated. 8 Ventilator-associated pneumonias potentially result in a 2-fold increase in length of stay, 6 and costs are estimated at $50 000 to $57 000 per occurrence. 9, 10 Endotracheal intubation and positive-pressure mechanical ventilation have direct and indirect effects on the lung and upper airways, the cardiovascular system, and the gastrointestinal system. Patients intubated for more than 72 hours are at high risk for VAP as a result of aspiration from the upper airways through small leaks around the endotracheal tube cuff. 11 Principal risk factors are those that favor the colonization of the oropharynx or the stomach, the aspiration of secretions into the lower respiratory tract or reflux of the gastrointestinal tract, and factors inherent in the host. 12 Oral hygiene is critical in the prevention of VAP because the aspiration of microorganisms present in the oropharynx constitutes the most common means of acquiring the disease. 12 The most common responsible organisms are Pseudomonas aeruginosa, enteric gram-negative rods, and Staphylococcus aureus.
11 Several strategies to prevent this colonization have been examined, including use of antibiotics and antiseptics such as chlorhexidine (CHX). Use of antibiotics has not been recommended secondary to the potential for development of resistant pathogens. 13 Chlorhexidine has a broad range of activity, acts rapidly, and remains chemically active for up to 6 hours. Chlorhexidine is effective against gram-positive organisms including methicillin-resistant S aureus and vancomycin-resistant enterococci.
14 Oral hygiene is critical in the prevention of VAP because the aspiration of microorganisms present in the oropharynx constitutes the most common means of acquiring the disease.
Review of the Literature
Interest in the use of CHX in preventing VAP is clearly evident by the plethora of meta-analyses that have been conducted about CHX usage. [15] [16] [17] [18] [19] The most recent meta-analysis and RCT 19 specifically examined the impact of 2.0% CHX to prevent VAP. The authors hypothesized that a higher concentration of CHX might be more effective. Only 1 prior study by Koeman and colleagues 14 was identified that evaluated 2.0% CHX as the sole intervention and tested it in mixed ICU patients. Noteworthy is that 2.0% CHX embedded in petroleum jelly was used in this study. These authors reported a significant reduction in the rate of VAP among patients in the CHX group. Tantipong and colleagues' 19 then conducted an RCT in an ICU setting. Patients in the CHX group received oral care 4 times per day that included brushing teeth, suctioning oral secretion, rubbing mucosa with 15 mL of a 2.0% CHX solution, continued until endotracheal tube removal. The incidence of VAP was 4.9% in the CHX group and 11.4% in the normal saline group (P = .08). The mean number of cases was 7 episodes per 1000 ventilator-days in the CHX group, and 21 episodes per 1000 ventilator-days in the normal saline group (P = .04). Of interest is that, in all patients, VAP was caused by gram-negative bacilli. No differences in mortality were demonstrated.
Mechanical cleaning of the oral cavity is an important component in reducing dental plaque and subsequent colonization. 20 Hutchins and colleagues 21 reported on a quality improvement project designed to reduce VAP. Oral care including brushing with cetylpyridinium chloride (later changed to 0.12% CHX), cleansing using suction swabs and hydrogen peroxide, mouth moisturizer, Berry and colleagues 22 conducted a single-blind randomized comparative study of mechanically ventilated patients. Patients were randomized to oral rinse with sterile water (group A), sodium bicarbonate (group B), or CHX 0.2% (group C). All subjects also had toothbrush cleaning with a nonfoaming toothbrush. No significant difference between the groups on clinical data was noted on admission. The incidence of VAP was 5% in groups B and C, and l% in group A. The authors suggested that mechanical cleaning with a toothbrush may be an important factor.
Conflicting results are evident from these metaanalyses, making recommendations for clinical practice difficult. 17 Numerous methodological issues make interpretation challenging, including differing diagnostic criteria for VAP; differing dosage, form, frequency, and duration of CHX treatment; and different patient populations. Table 1 clearly illustrates this point.
Studies in this area have been conducted as early as 1996. As can be seen, CHX dosages have ranged from 0.12% to 2.0%; the CHX has been administered in liquid or gel form, at a frequency ranging from daily to 4 times a day and continuing in some cases for up to 28 days.
Evidence-based guidelines are available, and some key ones, including those available from the IHI and the Centers for Disease Control (CDC), have recently been updated. In May 2010, 28 the IHI added a recommendation for CHX 0.12% solution to be used as part of the ventilator bundle, consistent with the US Food and Drug AdministrationYrecommended dosage. The IHI recommended development of an oral care process that includes the use of 0.12% CHX. Updated practice recommendations 29 for VAP prevention are illustrated on the CDC Web site (www.cdc.gov). The recommendations include performing regular oral care with an antiseptic solution and note that the optimal frequency is unresolved.
BACKGROUND
In 2005, the Rhode Island (RI) ICU Collaborative, a unique partnership between the state's ICUs, 2 RI quality organizations, RI Quality Institute, and the Hospital Association of RI, and insurers including Blue Cross & Blue Shield and United Healthcare of New England, was formed. The purpose of the collaborative was to create a quality improvement platform. 30 The RI ICU Collaborative, along with RI's hospital leaders, discussed the results of a quality improvement initiative in Michigan, the keystone project, and explored the possibility of replicating those results statewide. The successful Michigan model was built upon and applied in RI to put evidence into practice and improve the ICU quality culture. 31 The RI ICU Collaborative began by focusing on 2 hospital-acquired infections: catheter relatedYbloodstream infection and VAP. In 2002, the CDC, the Society of Critical Care Medicine, and the Infectious Disease Society of America 32 developed evidence-based guidelines for the prevention of specific hospital-acquired infections. From these guidelines, the ICU Collaborative established ''bundles'' as a means to meet the goal of reducing these 2 nosocomial infections. A bundle is a structured way of improving the processes of care and patient outcomes: a small, straightforward set of evidence-based practices, generally 3 to 5, that when performed collectively and reliably have been shown to improve patient outcomes. 25 As part of the comprehensive approach utilized by the RI ICU Collaborative, education of the nursing staff for the identified VAP reduction bundles occurred in March 2006. Best practice strategies included daily assessment of liberation from mechanical ventilation, elevation of the head of the bed, following commands as an indication of appropriate sedation, and using deep venous thrombosis and gastric stress ulcer prophylaxis. 28 At about the same time, and consistent with the literature, the Evidence-Based Practice and Research Council at the research site recommended that the cardiovascular thoracic (CVT) unit introduce CHX into oral care guidelines. Subsequently, an oral care protocol that specified that CHX 0.12% be applied orally to the oropharynx twice a day (every 12 hours) was implemented. Based on the literature, no recommendation Brainstorming included careful review of the existing protocol, where it was observed that CHX was applied in CVT every 12 hours to the oropharynx, but subsequently, every 4 hours, the oropharynx was cleansed with a foam swab. It was hypothesized that this subsequent oropharyngeal cleansing may have been inadvertently negating the effect of CHX. Chlorhexidine is poorly absorbed in the oral cavity. Under normal circumstances, 30% is retained in the oral cavity following CHX rinsing, and levels are not detected after 12 hours. 33 A change in protocol was proposed and approved that would be implemented in all critical care ventilated patients and would include oral care every 6 hours, including brushing or swabbing teeth and tongue and swabbing gums and mucosa, 0.12% CHX application every 6 hours, and moisturizer application to the lips after oral cleansing (Table 2) .
Competency assessments of oral care practices were conducted prior to implementing the revised protocol. A total of 30 registered nurses and respiratory therapists were randomly subjected to an oral care competency assessment over the course of 2 months to assess compliance with the existing protocol, including frequency of oral care, need for suctioning, and head of bed raised to at least 30 degrees. Seventy-eight percent of staff assessed completed oral care with complete adherence to protocol. The most frequent deviation was omission of deep oral suctioning. Compliance with documenting implementation of the existing oral care protocol before intervention ranged from 73% to 100%, with an average compliance of 93.7% for the 99 records evaluated.
This study examined the impact of the revised oral care protocol (Table 2) on VAP rates.
This study examined the impact of a revised oral care protocol.
METHODS

Purpose
The primary purpose of this study was to examine the impact of 0.12% CHX rinses and a rigorous oral care protocol including mechanical (toothbrushing) on VAP rates in critical care patients. Secondary purposes were to assess competency of staff related to the new protocol and audit documentation compliance and potentially evaluate cost avoidance.
Design
A quasi-experimental preintervention-postintervention design was used. The independent variable was the revised oral care protocol. The dependent variable was VAP rates defined as rate per 1000 ventilator-days.
Sample and Setting
The sample included all patients admitted to any of the 3 critical care units and on mechanical ventilation at any time during the 18-month study period (6 months The setting for this study was a private, 247-bed not-for-profit acute care teaching hospital in Providence, Rhode Island. The study was approved by an institutional review board.
Intervention
The intervention included the revised protocol (Table 2) along with a newly designed educational program. Education of staff related to the new protocol was conducted over a 2-month period through June 2009. Unit-based education was provided using a poster display set up in the nurses' break room. Information was presented in the SBAR (situation, background, assessment, recommendation) format. Changes in current practice and supporting evidence were outlined and discussed. Results of the preintervention competency assessment were shared with staff as feedback on their performance. Importance of deep oral suctioning during mouth care and before turning patients was emphasized. As part of protocol implementation, the way products were packaged and dispensed required changing, and staff were informed of that change. Individual 1-time-use packages had to be ordered and were changed in July 2009. Samples of the new oral care products were available, and staff had access to a relevant article summarizing the current evidence for the prevention of VAP. Staff were provided with the opportunity to apply for CE credit after reviewing the article. Nurses volunteered to serve as unit champions. Two from each unit were designated to be resource nurses and were available to reinforce the correct procedure and answer questions. Staff then completed an online test, with 95 % compliance, to verify understanding of the rationale, procedure, and frequency for the new oral care protocol.
Data Collection
Specific to the dependent variable, 6 months of retrospective preintervention data and 12 months of postintervention data were collected by the Infection Control Department following usual procedures. Aggregate incidence data were then shared with the primary researchers as part of their role as facilitators in the ICU Collaborative. Because data are collected in the aggregate, individuals were not identifiable.
RESULTS
VAP Rates
Six-month retrospective baseline data were collected to determine incidence rates of VAP prior to the study, which included the months from January through June 2009 ( Figure 1 ). The average VAP rate was 4.3 per 1000 ventilator-days, with a target of 2.4 days.
Twelve-month postintervention VAP data are presented in Figure 2 . The average VAP rate from August 2009 through July 2010 was decreased to 1.86 per 1000 ventilator-days. This reflects a rate decrease of 3.29 or a 63% reduction in VAP. Fourteen fewer VAPs occurred during the 12-month period after the CHX protocol was implemented, as compared with the prior 12 months, with an estimated cost avoidance of $700 000 to $798 000.
Postintervention Competency Assessment and Documentation Audits
Postimplementation staff competency assessment occurred over a 5-month period. After implementation, 91% of staff completed oral care with full adherence to the protocol. Staff reported that standardizing the oral care among critical care units at designated time intervals allowed for better compliance and also felt that the condition and cleanliness of the patients' oral mucosa had improved. Postimplementation chart audits conducted from August 2009 to July 2010 revealed compliance with documentation ranging from 83.3% to 100%, with average compliance at 96% for the 110 medical records evaluated.
SUMMARY AND CONCLUSIONS
Ventilator-associated pneumonia represents the most common nosocomial infection in ventilated patients and is associated with a 2-fold increase in length of stay and mortality rates of 40% to 80%. The primary purpose of this study was to examine the impact of 0.12% CHX rinses and a rigorous oral care protocol including mechanical (toothbrushing) on VAP rates in critical care patients. After implementation of the protocol, a significant decrease in VAP rates was demonstrated.
As illustrated in Figure 2 , at 8 of the 12 months' postimplementation of the revised oral care protocol, no VAPs occurred in the any of the 3 ICUs. During the 4 remaining months, a total of 5 VAPs occurred. In every instance where a VAP occurred, a root-cause analysis was performed at the unit level, and recommendations for improvement were made. In every case, these VAPs occurred in patients who were intubated for longer than 10 days and who were highly complex and with multiple comorbidities. In the state of Rhode Island, there is a limitation in the availability of subacute facilities able to care for patients requiring long-term mechanical ventilation. Therefore, patients potentially remain in The Miriam Hospital's ICUs for extended periods.
This study was limited by the fact that the database used to record and track VAP incidence does not include any demographic data. Thus, it was not possible to identify potential patient characteristics that might have contributed to VAP incidence. Also, the oral care protocol was intentionally comprehensive, which limits the ability to determine the independent impact of individual components, including CHX and mechanical toothbrushing. The potential influence of staff education on the VAP rate reduction is recognized. Clearly, further study is indicated.
KEY POINTS/IMPLICATIONS FOR NURSING PRACTICE
& An every 6-hour oral care protocol with CHX was effective in reducing VAP rates. Implementing the protocol in all of the critical care units, along with staff training, support, and tailoring products to meet provider needs, increased compliance with the protocol. & Ongoing monitoring is an essential part of the process.
Prospective data are collected daily to ensure that identified processes of care are completed and documented. If a variance is noted, the team member is approached and asked to verify and document rationale for the variance. Immediate feedback and ongoing education are provided as indicated. This process is respected by providers as valid and as an essential component of quality improvement. & Collaborative, interdisciplinary approaches are essential in implementing and sustaining change designed to improve patient outcomes. Physicians, nurses, pharmacists, and respiratory therapists have ongoing involvement and responsibility for ensuring success. The medical director routinely reviews the VAP prevention bundles with rotating medical staff, and new nursing staff are trained about the bundle and the oral care program during nursing orientation. Both ventilator-days and product usage data are supplied to the oral care company who then provides a compliance calculation, which is used to identify reeducation needs. The responsibility for preventing VAP rests with all providers. An evidencebased approach requires that nurses think ''out of the box,'' examine available quality data, and question whether the care that they are providing is optimal.
An every 6-hour oral care protocol with CHX was effective in reducing VAP rates.
In summary, a desire to further improve VAP rates spurned the authors to investigate whether changing the oral care protocol could result in continued reduction in VAP. A revised oral care protocol as a result of the study showed reduced VAP rates below the target and significant decrease in costs. 
